Federation Des Caisses Desjardins Du Quebec Adamis Pharmaceuticals Corp Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $17.5 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Aug 30, 2024
BUY
$2.1 - $3.21 $1,050 - $1,605
500 New
500 $1.13 Million
Q3 2018

Aug 30, 2024
SELL
$2.25 - $4.8 $1,462 - $3,120
-650 Reduced 56.52%
500 $1.75 Million
Q2 2018

Aug 30, 2024
SELL
$3.2 - $4.7 $4,320 - $6,345
-1,350 Reduced 54.0%
1,150 $3.68 Million
Q4 2017

Aug 30, 2024
BUY
$3.5 - $5.65 $1,750 - $2,825
500 Added 25.0%
2,500 $11 Million
Q3 2017

Aug 30, 2024
BUY
$4.5 - $5.65 $9,000 - $11,300
2,000
2,000 $10.5 Million

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email